Records containing: Overactive Bladder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-05-03A Mixed-methods Evaluation of the Clinical and Cost-effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
-
CLINICAL_TRIALS study record update · 2024-05-03Phase 2a Exploratory, Randomized, Double-blind, Parallel-group Study of ONO-8577 Compared to Combination of Solifenacin Succinate/ Mirabegron for Overactive Bladder
-
CLINICAL_TRIALS study record update · 2024-04-24Microbiomes of Pelvic Pain
-
CLINICAL_TRIALS study record update · 2024-04-16Impact of Decision Aids in Urogynecology
-
CLINICAL_TRIALS study record update · 2024-04-12Is Strong Desire to Void an Equivalent of Cognitive Task Affecting Balance in Older Women With Overactive Bladder?
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-04-09An Exploratory, Prospective, Multicenter, Randomized, Double Blind, Placebo + Sham Device Controlled, Study to Assess the Safety, Usability, and Initial Efficacy of the ViXe Combination for Intravesical Administration of XEOMIN® in the Treatment of Female Patients With Idiopathic Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2024-04-02Assessment of Efficacy of Mirabegron, Solifenacin, Tadalafil 5mg and Combination Therapy in Female Patients With Overactive Bladder: A Double Blinded Prospective Randomized Placebo -Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-03-26An Open-label Study to Evaluate the Pharmacokinetics and Safety of BAY 1817080 in Participants With Impaired Renal Function in Comparison to Matched Controls With Normal Renal Function
-
CLINICAL_TRIALS study record update · 2024-03-08A 8 Weeks, Randomized, Open Label, Parallel Group, Active Control Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB)
-
CLINICAL_TRIALS study record update · 2024-03-04Effectiveness and Safety of Acupuncture for Overactive Bladder in Adults: A Random Control Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-02-28Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms
-
CLINICAL_TRIALS study record update · 2024-02-28Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms
-
CLINICAL_TRIALS study record update · 2024-02-15The Urinary Microbiome Before and After Treatment With Intradetrusor Onabotulinum Toxin A Injection for Overactive Bladder
-
CLINICAL_TRIALS study record update · 2024-02-12Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA Efficacy and Safety in Women With Overactive Bladder and Urge Urinary Incontinence and the Value of Local Anesthesia for Pain Reduction
-
CLINICAL_TRIALS study record update · 2024-02-06Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-02-02Higher Neural and Cognitive Changes Following Anticholinergic Versus Beta 3 Agonist Versus Placebo Treatments in Female Patients With Overactive Bladder: a Multicenter Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2024-01-11Caffeine Reduction Education And Overactive Bladder Symptoms
-
CLINICAL_TRIALS study record update · 2024-01-05Evaluation of InterStim Micro System Performance and Safety (ELITE) to Confirm Long-Term Outcomes - Post Market Clinical Follow-Up Study
-
CLINICAL_TRIALS study record update · 2024-01-02Single-Dose Versus Multi-Dose Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
-
CLINICAL_TRIALS study record update · 2023-12-26Acupuncture Combined With Mirabegron in the Treatment of Overactive Bladder Syndrome: A Prospective Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-12-12A Prospective Study Evaluating the Feasibility of Telemedicine Use in the Overactive Bladder Clinical Care Pathway: a Non-inferiority Study Assessing Patient Satisfaction and Progression to Third Line Overactive Bladder Therapies
-
CLINICAL_TRIALS study record update · 2023-12-07Randomised Intervention Multicentre Study to Evaluate the Effect of Pelvic Floor Muscle Training in Men With BPH and OAB Treated With Silodosin - The SILODOSING Study
-
CLINICAL_TRIALS study record update · 2023-11-09The Effects of Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Urinary Frequency, Urgency and Urge Incontinence
-
CLINICAL_TRIALS study record update · 2023-11-02Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection: a Non-Inferiority Trial
-
CLINICAL_TRIALS study record update · 2023-10-23Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence: A Sham-Controlled Trial